For every 10 mg/dl decline in plasma ApoB concentration attributable to LPL score-associated variants, a parallel decrease of 0.8 mmol/L (69.9 mg/dl) in TG concentration is observed, with no discernible alteration in LDL-C, and a diminished risk of CHD (odds ratio (OR), 0.771 [95% CI, 0.741–0.802]). The gene discussed is APOB; the disease is coronary artery disorder.